Loading organizations...
Loading organizations...
Developing treatments for acute hearing loss and related disorders.
Otologic Pharmaceutics has raised $4.1M across 1 funding round.
Otologic Pharmaceutics has raised $4.1M in total across 1 funding round.
Otologic Pharmaceutics has raised $4.1M in total across 1 funding round.
Otologic Pharmaceutics's investors include Richard Gammans, Oklahoma Life Science Fund.
Otologic Pharmaceutics has raised $4.1M across 1 funding round. Most recently, it raised $4.1M Series A in April 2014.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 4, 2014 | $4.1M Series A | Richard Gammans | Oklahoma Life Science Fund |